Modern Medicine News

5 steps to maximize your optical profitThe key to optical success lies with the OD's involvement, according to Nazanin Galehdari, OD. She offers 5 steps to improve optical profitability.
Involve patients in monitoring IOP
Involve patients in monitoring IOPMonitoring and measuring a glaucoma patient's intraocular pressure can be challenging with patients' busy schedules. Optometry Times Chief Optometric Editor Benjamin P. Casella, OD, FAAO, gives his reasons why home tonometry can help drive a treatment partnership between doctor and patient.
Taming the Wild West of mobile healthcareWithin the past decade, over 165,000 mobile health apps have launched, with thousands more on the way.
CMS changes impacting primary care for the better
CMS changes impacting primary care for the betterA look at how Medicare is reforming primary care payment.
Latest research brings awareness to new AMD discoveriesResearch on treatments and/or causes of age-related macular degeneration (AMD) covers a wide range of approaches and paradigms. The latest research published in the past three months are perfect examples for understanding and treating AMD.
Resolve patient confusion with AMD awareness, understandingAge-related macular degeneration (AMD) is the leading cause of significant visual acuity loss in people over the age of 50 in developed countries. Almost 80% of the people diagnosed with AMD will have the non-neovascular (dry) or atrophic subtypes. Here is the clinical information patients need to understand this disease.
Bryan Wolynski, OD, FAAO: Owner of Glasses on First in New York CityBryan Wolynski, OD, FAAO, and owner of Glasses on First in New York City, talks about falling into low vision, working with family, and driving blind in the latest Optometry Times Q&A.
From new vaccines to the advent of new neurotoxinsPhysicians weigh in expectations for new developments within all facets of dermatology from pediatric dermatology to dermatopathology.
Ustekinumab shows promise for reducing psoriasis-associated cardiovascular comorbidityInitial results of an investigator-initiated phase 4 trial suggest that blocking interleukin-12 (IL-12) and IL-23 may reduce cardiovascular inflammation associated with psoriasis, researchers reported at AAD 2018.
Laddered treatment for pityriasis rubra pilarisDiagnosing PRP is challenging because it can mimic eczema, psoriasis, or even ichthyosis. Biologic treatment for refractory cases considered, researchers said at AAD 2018.